Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2307172,Activ4,Activity QTL 4,3.71,0.00023,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),16,1,34465490,Rat,n/a,region,qtl 1000,61472,Aia1,Adjuvant induced arthritis QTL 1,18,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),20,3151815,6896013,Rat,n/a,region,qtl 1000,2317057,Aia27,Adjuvant induced arthritis QTL 27,2.83,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),20,3402111,27968216,Rat,n/a,region,qtl 1000,737826,Alc11,Alcohol consumption QTL 11,3.2,,consumption behavior trait (VT:0002069),ethanol drink intake rate (CMO:0001407),16,5013802,64012784,Rat,n/a,region,qtl 1000,631830,Alc7,Alcohol consumption QTL 7,2.9,,consumption behavior trait (VT:0002069),ethanol drink intake rate (CMO:0001407),16,1,27556253,Rat,n/a,region,qtl 1000,2317851,Alcrsp22,Alcohol response QTL 22,3.2,0.05,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),20,1,26305996,Rat,n/a,region,qtl 1000,1641893,Alcrsp7,Alcohol response QTL 7,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),20,1,26305996,Rat,n/a,region,qtl 1000,1600378,Arunc4,Aerobic running capacity QTL 4,,0.03,exercise endurance trait (VT:0002332),maximum distance run on treadmill (CMO:0001406),16,1090054,86162972,Rat,n/a,region,qtl 1000,1300152,Bp195,Blood pressure QTL 195,3.46,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),20,4855468,9899946,Rat,n/a,region,qtl 1000,61338,Bp23,Blood pressure QTL 23,4.3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),16,5013802,50013802,Rat,n/a,region,qtl 1000,2306902,Bp339,Blood pressure QTL 339,,0.01,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),16,4136355,45905331,Rat,n/a,region,qtl 1000,70183,BpQTLcluster13,Blood pressure QTL cluster 13,3.654,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),16,5013802,45905331,Rat,n/a,region,qtl 1000,70183,BpQTLcluster13,Blood pressure QTL cluster 13,3.654,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),16,5013802,45905331,Rat,n/a,region,qtl 1000,70183,BpQTLcluster13,Blood pressure QTL cluster 13,3.654,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),16,5013802,45905331,Rat,n/a,region,qtl 1000,6893685,Bw111,Body weight QTL 111,2.7,0.004,body mass (VT:0001259),body weight (CMO:0000012),20,1,33300419,Rat,n/a,region,qtl 1000,6903319,Bw114,Body weight QTL 114,2.7,0.0037,body mass (VT:0001259),body weight (CMO:0000012),16,244593,45244593,Rat,n/a,region,qtl 1000,8694189,Bw153,Body weight QTL 153,3.13,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),20,1,28375393,Rat,n/a,region,qtl 1000,2303566,Bw90,Body weight QTL 90,2,,body mass (VT:0001259),body weight (CMO:0000012),16,1,41240937,Rat,n/a,region,qtl 1000,2312660,Bw95,Body weight QTL 95,,0.05,inguinal fat pad mass (VT:0010424),inguinal fat pad weight to body weight ratio (CMO:0001253),16,1550187,63210301,Rat,n/a,region,qtl 1000,1331772,Cdexp2,CD45RC expression in CD8 T cells QTL 2,5.7,,CD8-positive T cell quantity (VT:0008077),blood CD45RChigh CD8 T cell count to CD45RClow CD8 T cell count ratio (CMO:0001990),20,4855468,10800530,Rat,n/a,region,qtl 1000,61432,Cia1,Collagen induced arthritis QTL 1,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),20,4855475,15050565,Rat,n/a,region,qtl 1000,61448,Ciaa1,CIA Autoantibody QTL 1,30,0.001,blood autoantibody amount (VT:0003725),calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281),20,3151815,6896013,Rat,n/a,region,qtl 1000,1641915,Colcr9,Colorectal carcinoma resistance QTL 9,2.97,0.0024,intestine integrity trait (VT:0010554),benign colorectal tumor number (CMO:0001795),20,2999707,47999707,Rat,n/a,region,qtl 1000,1354642,Despr15,Despair related QTL 15,,0.0027,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),20,1,24652101,Rat,n/a,region,qtl 1000,1354584,Despr6,Despair related QTL 6,3.1,0.0067,locomotor behavior trait (VT:0001392),amount of time spent in voluntary immobility (CMO:0001043),16,1,41240937,Rat,n/a,region,qtl 1000,1354625,Despr7,Despair related QTL 7,3.16,0.016,locomotor behavior trait (VT:0001392),amount of time spent in voluntary immobility (CMO:0001043),16,1728297,46728297,Rat,n/a,region,qtl 1000,61474,Eae1,Experimental allergic encephalomyelitis QTL 1,3,,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),20,4039113,5875448,Rat,n/a,region,qtl 1000,1600382,Edcs3,Endometrial carcinoma susceptibility QTL3,3.5,0.003,uterus morphology trait (VT:0001120),percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759),20,1,25653396,Rat,n/a,region,qtl 1000,7411650,Foco23,Food consumption QTL 23,20.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),20,1,28375393,Rat,n/a,region,qtl 1000,7411664,Foco30,Food consumption QTL 30,11,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),16,1340741,46340741,Rat,n/a,region,qtl 1000,7411668,Foco32,Food consumption QTL 32,8,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),20,1,37550487,Rat,n/a,region,qtl 1000,70205,Gcr3,Gastric cancer resistance QTL 3,2.3,,stomach morphology trait (VT:0000470),stomach tumor depth of invasion (CMO:0001888),16,19398187,70590230,Rat,n/a,region,qtl 1000,70205,Gcr3,Gastric cancer resistance QTL 3,2.3,,stomach morphology trait (VT:0000470),stomach tumor depth of invasion (CMO:0001888),16,19398187,70590230,Rat,n/a,region,qtl 1000,70205,Gcr3,Gastric cancer resistance QTL 3,2.3,,stomach morphology trait (VT:0000470),stomach tumor diameter (CMO:0001889),16,19398187,70590230,Rat,n/a,region,qtl 1000,70205,Gcr3,Gastric cancer resistance QTL 3,2.3,,stomach morphology trait (VT:0000470),stomach tumor diameter (CMO:0001889),16,19398187,70590230,Rat,n/a,region,qtl 1000,2293343,Glom16,Glomerulus QTL 16,7.4,,kidney glomerulus integrity trait (VT:0010546),kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269),16,1550187,49247447,Rat,n/a,region,qtl 1000,737819,Hcas4,Hepatocarcinoma susceptibility QTL 4,4.43,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),16,5013802,50169318,Rat,n/a,region,qtl 1000,1600369,Hcas8,Hepatocarcinoma susceptibility QTL 8,,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),16,1,24228366,Rat,n/a,region,qtl 1000,631561,Hcuc2,Hepatic copper content QTL 2,2.8,,hepatic copper amount (VT:0003065),liver total copper weight (CMO:0001507),16,1,41240957,Rat,n/a,region,qtl 1000,2305926,Iddm37,Insulin dependent diabetes mellitus QTL 37,6,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),20,2018654,47018654,Rat,n/a,region,qtl 1000,2312666,Insul16,Insulin level QTL 16,,0.01,blood insulin amount (VT:0001560),serum insulin level (CMO:0000358),16,1550187,63210301,Rat,n/a,region,qtl 1000,9589155,Insul32,Insulin level QTL 32,6.38,0.001,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),20,1,28375393,Rat,n/a,region,qtl 1000,1582235,Insul8,Insulin level QTL 8,3.3,0.0063,blood insulin amount (VT:0001560),calculated serum insulin level (CMO:0000359),16,1,27556253,Rat,n/a,region,qtl 1000,1598816,Memor12,Memory QTL 12,2.4,,exploratory behavior trait (VT:0010471),average horizontal distance in proximity to the target during voluntary locomotion in an experimental apparatus (CMO:0002674),20,4108956,49108956,Rat,n/a,region,qtl 1000,61405,Niddm6,Non-insulin dependent diabetes mellitus QTL 6,3.66,0.001,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),16,5013802,52144919,Rat,n/a,region,qtl 1000,2306850,Pia40,Pristane induced arthritis QTL 40,,0.0001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),20,2018770,6567419,Rat,n/a,region,qtl 1000,1558640,Prcs2,Prostate cancer susceptibility QTL 2,3.3,,prostate integrity trait (VT:0010571),percentage of study population developing ventral prostate tumorous lesions during a period of time (CMO:0000943),20,4039113,18872273,Rat,n/a,region,qtl 1000,4889857,Pur27,Proteinuria QTL 27,12.2,0.001,total urine protein amount (VT:0000032),urine total protein excretion rate (CMO:0000756),20,4039113,18872273,Rat,n/a,region,qtl 1000,634355,Rends4,Renal damage susceptibility QTL 4,,0.05,kidney blood vessel morphology trait (VT:0000530),organ lesion measurement (CMO:0000677),16,1,27556253,Rat,n/a,region,qtl 1000,1300133,Rf24,Renal function QTL 24,3.64,,blood creatinine amount (VT:0005328),creatinine clearance (CMO:0000765),16,4136355,23105837,Rat,n/a,region,qtl 1000,631517,Scl9,Serum cholesterol level QTL 9,3.3,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),16,17309396,22744540,Rat,n/a,region,qtl 1000,9590252,Scort12,Serum corticosterone level QTL 12,20.46,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),20,1,37550487,Rat,n/a,region,qtl 1000,9590275,Scort15,Serum corticosterone level QTL 15,3.48,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),20,1,28375393,Rat,n/a,region,qtl 1000,9590151,Scort8,Serum corticosterone level QTL 8,8.45,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),16,1,31816439,Rat,n/a,region,qtl 1000,9590109,Sffal8,Serum free fatty acids level QTL 8,5.32,0.01,blood free fatty acid amount (VT:0001553),plasma free fatty acids level (CMO:0000546),20,1,28375393,Rat,n/a,region,qtl 1000,2302380,Slep6,Serum leptin concentration QTL 6,3.36,,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),16,1,33160624,Rat,n/a,region,qtl 1000,2312663,Slep9,Serum leptin concentration QTL 9,,0.001,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),16,1550187,63210301,Rat,n/a,region,qtl 1000,2312669,Stl23,Serum triglyceride level QTL 23,,0.01,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),16,1550187,63210301,Rat,n/a,region,qtl 1000,7175096,Tcs1,T cell selection QTL 1,,,T cell selection,expression,20,3910555,5533640,Rat,n/a,region,qtl 1000,7387283,Uae44,Urinary albumin excretion QTL 44,,0.1712,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),20,1,27357423,Rat,n/a,region,qtl